Dr. Anna Zajakina is the head of Cancer Gene Therapy group at Latvian Biomedical Research and Study Centre. She has completed her PhD in 2005 at University of Latvia, Molecular Biology, Virology and Biochemistry Division. She raised her expertise at University of Rostock (Germany), Uppsala University (Sweden) and University of Bordeaux (France). Dr. Zajakina is the author of more than 40 papers and conference presentations related to cancer research, molecular biology and virology issues. The main research interests include the development of novel clinically translatable methods for cancer treatment based on gene therapy vectors and combination of treatment strategies with chemotherapy and immunotherapy. Currently, Dr. Zajakina leads two collaborative research projects focused on delivery of therapeutic genes by viral vectors into tumors for smart regulation of tumor microenvironment in combination of polyfunctional magnetic nanoparticles. Being a national coordinator of European Biotechnology Thematic Network Association, Dr. Zajakina is actively taking part in organization and hosting of international workshops, seminars and conferences, working in cooperation with students and researchers representing various organizations.